![Hian Leng Ngiam](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hian Leng Ngiam
Directeur Général chez
ESSEX BIO-TECHNOLOGY LIMITED
Fortune : 634 455 $ au 31/07/2026
Profil
Hian Leng Ngiam currently works at Essex Bio-Technology Ltd., as Chief Executive Officer & Executive Director from 2025, Essex Bio-Investment Ltd., as President & Director from 2018, Antikor Biopharma Ltd., as Director from 2019, Essex Bio-Pharmacy Ltd., as Director, Essex Medipharma (Zhuhai) Co., Ltd., as Director, Zhuhai Essex Bio-Pharmaceutical Co., Ltd., as Director, Uno Medical Group Pvt Ltd., as Director, and Majeton Pte Ltd., as Director.
Mr. Ngiam received his undergraduate degree from Imperial College London.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 2 039 000 ( 0,36% ) | 634 455 $ | 31/07/2026 |
Postes actifs de Hian Leng Ngiam
| Sociétés | Poste | Début |
|---|---|---|
| ESSEX BIO-TECHNOLOGY LIMITED | Directeur Général | 01/07/2025 |
Essex Bio-Investment Ltd.
 Essex Bio-Investment Ltd. Financial ConglomeratesFinance Investment holding company | President | 01/01/2018 |
Zhuhai Essex Bio-Pharmaceutical Co., Ltd.
 Zhuhai Essex Bio-Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
Essex Bio-Pharmacy Ltd.
 Essex Bio-Pharmacy Ltd. Investment ManagersFinance Functions as a Pension/Retirement Fund | Directeur/Membre du Conseil | - |
Antikor Biopharma Ltd.
 Antikor Biopharma Ltd. BiotechnologyHealth Technology Develops novel biologically-targeted photodynamic therapeutic agents | Directeur/Membre du Conseil | 21/01/2019 |
Majeton Pte Ltd. | Directeur/Membre du Conseil | - |
Uno Medical Group Pvt Ltd. | Directeur/Membre du Conseil | - |
Essex Medipharma (Zhuhai) Co., Ltd. | Directeur/Membre du Conseil | - |
Formation de Hian Leng Ngiam
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Essex Bio-Technology Ltd.
 Essex Bio-Technology Ltd. Medical SpecialtiesHealth Technology Operates as an investment holding company through subsidiary which develops, manufactures & sells biopharmaceutical products | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Essex Bio-Investment Ltd.
Essex Bio-Investment Ltd. Financial ConglomeratesFinance Investment holding company | Finance |
Antikor Biopharma Ltd.
Antikor Biopharma Ltd. BiotechnologyHealth Technology Develops novel biologically-targeted photodynamic therapeutic agents | Health Technology |
Essex Bio-Pharmacy Ltd.
Essex Bio-Pharmacy Ltd. Investment ManagersFinance Functions as a Pension/Retirement Fund | Finance |
Essex Medipharma (Zhuhai) Co., Ltd. | |
Zhuhai Essex Bio-Pharmaceutical Co., Ltd.
Zhuhai Essex Bio-Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Uno Medical Group Pvt Ltd. | |
Majeton Pte Ltd. |
